Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesMerit Medical Systems Inc

Merit Medical Systems Inc

Healthcare Medical Instruments & Supplies
PortfolioPortfolio WatchlistWatchlist
Company price
84.16 USD -0.15 ( 0.18%)
Last update at 2026-11-03T21:00:00Z
VOLUME
792492
Market Cap
5145.84M
P/E
35.76

Momentum Score

…

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
83.56
Low
85.06
High
52 Week Price Range
59.74
Low
94.75
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
84.31
Dividend Yield
-
Revenue TTM
1578.81M
Revenue Per Share
26.56
Gross Profit TTM
781.73M
Debt / Equity
0.57
ROE
9.19%
Net Debt
449.73M
ROCE
8.07%
Diluted EPS TTM
2.41

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 170.94M 149.99M 112.09M 82.63M 53.92M
Net income 128.49M 120.36M 94.41M 74.52M 48.45M
Selling general administrative 455.21M 399.73M 361.17M 342.52M 335.69M
Gross profit 736.94M 643.33M 583.87M 519.10M 485.33M
Reconciled depreciation 134.65M 114.73M 98.05M 92.20M 95.78M
Ebit 197.40M 159.24M 127.60M 87.56M 60.92M
Ebitda 332.05M 273.97M 228.89M 194.67M 172.44M
Depreciation and amortization 134.65M 114.73M 101.29M 107.10M 111.53M
Non operating income net other - - - 1.41M -1.74M
Operating income 184.38M 155.69M 123.94M 87.56M 60.92M
Other operating expenses 1330.35M 1200.82M 1133.42M 1049.92M 996.36M
Interest expense 26.46M 31.22M 15.51M 6.34M 5.26M
Tax provision 42.45M 29.64M 10.59M 8.11M 5.46M
Interest income 15.07M 26.23M 0.66M 0.44M 0.77M
Net interest income -11.39M -4.99M -12.04M -5.90M -4.49M
Non recurring - - - 8.89M 14.32M
Income tax expense 42.45M 29.64M 17.68M 8.11M 5.46M
Total revenue 1514.73M 1356.51M 1257.37M 1150.98M 1074.75M
Total operating expenses 552.57M 487.64M 458.73M 418.04M 406.94M
Cost of revenue 777.79M 713.18M 673.49M 631.88M 589.42M
Total other income expense net -13.44M -5.70M -11.86M -4.93M -7.00M
Net income from continuing ops 128.49M 120.36M 100.18M 74.52M 48.45M
Net income applicable to common shares - - - 74.52M 48.45M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 2685.92M 2418.60M 2325.24M 1663.97M 1648.29M
Intangible assets 537.65M 498.26M 325.88M 275.87M 319.27M
Other current assets 34.33M 31.83M 26.20M 22.32M 16.15M
Total liab 1101.62M 1039.24M 1123.24M 519.57M 608.50M
Total stockholder equity 1584.30M 1379.36M 1202.00M 1144.40M 1039.80M
Deferred long term liab - - - 33.73M 49.61M
Other current liab 163.40M 134.08M 120.45M 129.89M 161.55M
Common stock 763.91M 703.22M 638.15M 675.17M 641.53M
Capital stock 763.91M 703.22M 638.15M 675.17M 641.53M
Retained earnings 824.03M 695.54M 575.18M 480.77M 406.26M
Other liab - - - 52.43M 76.29M
Good will 506.84M 463.51M 382.24M 359.82M 361.74M
Other assets - 38.88M - 31.93M 47.50M
Cash 448.50M 376.71M 589.14M 58.41M 67.75M
Total current liabilities 239.76M 216.40M 203.56M 220.65M 236.28M
Current deferred revenue - - 5.09M - -
Net debt 449.73M 417.95M 302.22M 210.34M 247.28M
Short term debt 10.88M 10.33M 12.09M 22.25M 19.11M
Short long term debt - - - 11.25M 8.44M
Short long term debt total 898.23M 794.66M 891.36M 268.75M 315.03M
Other stockholder equity - - - -11.55M -7.99M
Property plant equipment - - - 382.98M 437.57M
Total current assets 1040.15M 923.77M 1108.47M 529.08M 482.21M
Long term investments 28.74M 22.83M 19.06M 15.58M 14.71M
Net tangible assets - - - 508.70M 358.79M
Short term investments - - 1.50M - -
Net receivables 223.61M 209.17M 189.26M 178.45M 172.84M
Long term debt 734.04M 729.55M 823.01M 186.76M 234.40M
Inventory 333.70M 306.06M 303.87M 265.99M 221.92M
Accounts payable 60.55M 68.50M 65.94M 68.50M 55.62M
Accumulated other comprehensive income -3.64M -19.40M -11.33M -11.55M -7.99M
Common stock total equity - - - 675.17M 641.53M
Retained earnings total equity - - - 480.77M 406.26M
Non currrent assets other 32.57M 42.50M 32.27M 28.78M 26.71M
Non current assets total 1645.77M 1494.83M 1216.77M 1134.88M 1166.08M
Capital lease obligations 87.53M 65.11M 68.35M 70.74M 72.19M
Long term debt total - - - 186.76M 234.40M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -368.65M -184.33M -57.40M -37.16M
Change to liabilities - - - 12.66M 6.05M
Total cashflows from investing activities -247.39M -368.65M - -57.40M -37.16M
Net borrowings 0.00M -99.06M - -44.94M -108.50M
Total cash from financing activities 16.00M -60.01M 559.27M -60.26M -98.44M
Change to operating activities - - - -27.06M -17.84M
Net income 128.49M 120.36M 94.41M 74.52M 48.45M
Change in cash 69.78M -210.38M 528.58M -7.19M 10.83M
Begin period cash flow 378.77M 589.14M 60.56M 67.75M 56.92M
End period cash flow 448.55M 378.77M 589.14M 60.56M 67.75M
Total cash from operating activities 297.37M 220.80M 145.15M 114.29M 147.23M
Issuance of capital stock 28.21M 40.91M 24.78M 20.07M 21.31M
Depreciation 134.65M 114.73M 101.29M 92.20M 95.78M
Other cashflows from investing activities -17.78M -10.43M - -12.37M -2.05M
Dividends paid - - - 2.47M 0.58M
Change to inventory -21.60M -2.29M -32.10M -47.93M -25.18M
Change to account receivables -2.73M -21.70M -9.54M -15.12M -8.62M
Sale purchase of stock - - -5.12M -2.47M -0.58M
Other cashflows from financing activities -12.21M -1.85M 1162.58M -30.44M -10.09M
Change to netincome - - - 39.77M 20.83M
Capital expenditures 84.84M 38.04M 36.70M 45.03M 27.94M
Cash and cash equivalents changes - - - -3.37M 11.63M
Change in working capital -23.34M -36.95M -70.02M -71.40M -17.84M
Stock based compensation 43.46M 28.47M 21.33M 18.04M 16.09M
Other non cash items 8.90M 9.05M 10.78M 15.86M 9.37M
Free cash flow 212.53M 182.76M 108.45M 69.26M 119.29M

Peer Comparison*

Sector: Healthcare Industry: Medical Instruments & Supplies

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
MMSI
Merit Medical Systems Inc		 -0.15
0.18%		 84.16 35.76 18.90 3.26 3.09 3.53 15.38
ISRG
Intuitive Surgical Inc		 3.88
0.89%		 440.75 43.30 31.35 12.25 7.35 11.63 30.22
ESLOF
EssilorLuxottica Société anonyme		 -2.00
0.95%		 208.00 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA		 -1.89
1.80%		 103.04 41.68 27.25 3.94 2.45 3.71 16.04
BDX
Becton Dickinson and Company		 -0.66
0.33%		 197.94 31.62 13.76 2.25 2.04 2.93 13.40

Profile*

Merit Medical Systems Inc

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.

1600 West Merit Parkway, South Jordan, UT, United States, 84095

801 253 1600

https://www.merit.com

7500

Name Title Year Born
Mr. Fred P. Lampropoulos Founder, Chairman, CEO & Pres 1950
Mr. Raul Parra Jr., CPA CFO & Treasurer 1979
Mr. Brian G. Lloyd Chief Legal Officer & Corp. Sec. 1961
Mr. Joseph C. Wright Chief Commercial Officer 1970
Mr. Neil Peterson Chief Operating Officer NA
Mr. Jason Treft Chief Technology Officer NA
Mr. Joseph Pierce Chief Information Officer NA
Mr. Michel J. Voigt Chief HR Officer 1973
Mr. John Knorpp Chief Regulatory Affairs Officer NA
Dr. Nicole Priest Chief Wellness Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

VNP
CAD 32.54
+24.44%
HUT
CAD 88.32
+14.81%
KEEL
CAD 3.05
+14.66%
MTY
CAD 36.63
+13.58%
CNL
CAD 15.98
+11.90%
MOON
CAD 4.72
-12.34%
EU
CAD 0.96
-8.57%
URE
CAD 1.02
-8.48%
AP-UN
CAD 3.71
-8.17%
HG
CAD 3.77
-8.05%

Equity Sectors*

  • Basic Materials

    -1.14%

  • Communication Services

    +0.65%

  • Consumer Cyclical

    +0.09%

  • Consumer Defensive

    -0.57%

  • Energy

    -0.15%

  • Financial Services

    +0.08%

  • Healthcare

    +2.18%

  • Industrials

    +2.04%

  • Real Estate

    -0.25%

  • Technology

    +1.02%

  • Utilities

    +0.66%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…